Sino Biological launches 4RISE™ high-throughput wet-lab services to accelerate AI-driven drug discovery
AI is helping researchers design new proteins that can bind to specific targets. However, scientists still need to test these computer-designed proteins in the lab to see if they actually work. To help with this, Sino Biological, Inc., a global leader in recombinant technology, has announced 4RISE™ high-throughput lab testing services for AI-designed protein binders.
Image Credit: Sino Biological Inc.
The services include protein production in just 3 hours, AI-ready binding data in as little as 3 days, and real-time access to organized target-binding data through an API. These features help researchers working with AI in life sciences work faster and better understand their results. Designed for repeated rounds of AI-based discovery, 4RISE™ brings together fast lab testing, large-scale screening processes, and organized data delivery. This supports a continuous cycle of designing, testing, and learning.
"3 hours" and "3 days"
Sino Biological's XPressMAX™ Cell-Free Protein Synthesis (CFPS) platform can produce recombinant proteins in just 3 hours. In established workflows, its success rate is higher than 99%. The platform can produce miniproteins, VHHs, scFvs, Fabs, enzymes, and cytokines. This helps researchers test AI-designed protein candidates sooner and get feedback faster, allowing them to improve their designs more quickly.
4RISE™ uses Carterra high-throughput SPR, Biacore SPR, and Octet BLI technologies to screen protein binding on a large scale, study binding behavior over time, and measure binding strength. When combined with CFPS, the process can deliver AI-ready binding data from a protein sequence in as little as 3 days. Researchers can access organized binding data in real time through an API, making it easier to collect the information for further research and analysis.
Four fast screening services for AI-designed binders
To meet different research needs, 4RISE™ offers flexible ways to screen and study AI-designed protein binders. Each service is designed for different types of candidates and testing goals. Rapid Hit Discovery looks for miniproteins and VHHs that can bind to a target by testing crude liquid samples. Comparative Binder Screening tests purified candidates under the same conditions to help researchers decide which ones are most promising. Affinity & Kinetic Characterization measures how strongly and how quickly candidates bind, helping researchers choose leading candidates. Specialized Binder Expression & Validation supports different types of protein binders through specially designed mammalian cell production and binding tests.
In addition to binding tests, 4RISE™ offers more than 20 tests to check how suitable candidates may be for further development, over 1,000 protein activity tests, and more than 10 tests that measure how proteins work in cells. These services help researchers study candidates in greater detail and improve their designs.
Proven experience
Sino Biological works with AI companies to test AI-designed antibodies, newly designed protein binders, and proteins created through computer-based engineering. Its 4RISE™ lab testing services have supported research published in Science, Nature Communications, Scientific Reports, and other leading scientific journals.
Molecules designed by AI need reliable lab test results to show what they can do. Our combined services provide the high-quality data researchers need to test candidates quickly, shorten design cycles, and turn promising discoveries into real-world uses.
Dr. Rob Burgess, Chief Business Officer, Sino Biological US

